Elafibranor

Overview

Elafibranor is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3707395).

API suppliers (1)

Suppliers of Elafibranor evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Maithri Laboratories Private LimitedIndia1 active DMF GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Elafibranor expires 5 Mar 2044 and exclusivity 10 Jun 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

2-[2,6-dimethyl-4-[(E)-3-(4-methylsulfanylphenyl)-3-oxoprop-1-enyl]phenoxy]-2-methylpropanoic acid

Canonical SMILES

CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)/C=C/C(=O)C2=CC=C(C=C2)SC

InChIKey

AFLFKFHDSCQHOL-IZZDOVSWSA-N